Award disclosed
Jon P. Stonehouse
Director
Common Stock
- Value context
- $6.25K
- Reported price
- $9.70 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
BIOCRYST PHARMACEUTICALS INC
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 32 trades on this page.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Automatic Stock Option Grant
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Emp. Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief R&D Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief R&D Officer
Emp. Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockGrant or award | 644$9.70 / share | $6.25K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,288$9.70 / share | $12.49K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,159$9.70 / share | $11.24K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 644$9.70 / share | $6.25K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,288$9.70 / share | $12.49K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 15,294Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Automatic Stock Option GrantGrant or award | Derivative units33,540Award · no purchase price | Non-cash award | Jun 11Filed Jun 15 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,262$8.91 / share | $11.24K | May 29Filed Jun 2 · 4d later | SEC filing |
| Director | Common StockGrant or award | 631$8.91 / share | $5.62K | May 29Filed Jun 2 · 4d later | SEC filing |
| Director | Common StockGrant or award | 631$8.91 / share | $5.62K | May 29Filed Jun 2 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,122$8.91 / share | $10K | May 29Filed Jun 2 · 4d later | SEC filing |
| Director | Common StockGrant or award | 1,262$8.91 / share | $11.24K | May 29Filed Jun 2 · 4d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 62,500$5.04 / share | $315K | May 13Filed May 15 · 2d later | SEC filing |
| Chief Legal Officer | Emp. Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units62,500$5.04 exercise / conversion price | Not a separate purchase | May 13Filed May 15 · 2d later | SEC filing |
| Chief R&D Officer | Common StockGrant or award | 205,150Award · no purchase price | Non-cash award | Apr 6Filed Apr 7 · 1d later | SEC filing |
| Chief R&D Officer | Emp. Stock Option (Right to Buy)Grant or award | Derivative units441,350Award · no purchase price | Non-cash award | Apr 6Filed Apr 7 · 1d later | SEC filing |
BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.